[Introduction of genetic analysis can provide us with safer doping tests. Large variation in androgen turnover creates problems in current tests]

Lakartidningen. 2012;109(29-31):1347-9.

[Article in Swedish]

Authors

Anders Rane¹, Lena Ekström

Affiliation

¹ Avdelningen för klinisk farmakologi, institutionen för laboratoriemedicin, Karolinska institutet, Karolinska universitetssjukhuset, Huddinge. anders.rane@ki.se

PMID: 22913116

No abstract available

Publication types

Review

MeSH terms

Androgens / genetics
Androgens / metabolism*
Cyclic Nucleotide Phosphodiesterases, Type 7 / genetics
Cyclic Nucleotide Phosphodiesterases, Type 7 / metabolism
Doping in Sports* / ethnology
Epitestosterone / genetics
Epitestosterone / metabolism
Epitestosterone / urine
Genotype
Genotyping Techniques*
Glucuronosyltransferase / genetics
Glucuronosyltransferase / metabolism
Humans
Minor Histocompatibility Antigens
Sensitivity and Specificity
Steroid 17-alpha-Hydroxylase / genetics
Steroid 17-alpha-Hydroxylase / metabolism
Testosterone / genetics
Testosterone / metabolism*
Testosterone / urine

Substances

Androgens
Minor Histocompatibility Antigens
Testosterone
Epitestosterone
Steroid 17-alpha-Hydroxylase
Glucuronosyltransferase
UGT2B17 protein, human
Cyclic Nucleotide Phosphodiesterases, Type 7
PDE7B protein, human